Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$990M |
 |
MedtronicMDT |
-$67M |
 |
Edwards LifesciencesEW |
-$745M |
 |
Intuitive SurgicalISRG |
-$1.08B |
 |
RxSightRXST |
-$362M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Peters Stanley W III | Jun 14, 2024 | Sell | 4,000 | $71.82 | $290,000 |
| BRONSON DAVID M | May 13, 2024 | Buy | 1,350 | $72.09 | $97,000 |
| Schwarzentraub Barbara J | May 8, 2024 | Buy | 1,442 | $69.26 | $100,000 |
| Aronson Martha Goldberg | May 6, 2024 | Buy | 2,000 | $70.98 | $140,000 |
| Beyer Pat | Apr 30, 2024 | Buy | 3,000 | $68.3 | $200,000 |
| Peters Stanley W III | Dec 4, 2023 | Sell | 2,300 | $109.9276 | $250,000 |
| Peters Stanley W III | Nov 7, 2023 | Sell | 1,200 | $102.395 | $120,000 |
| Peters Stanley W III | Sep 13, 2023 | Sell | 2,000 | $107.3146 | $210,000 |
| Garner Todd W | Aug 16, 2023 | Sell | 1,355 | $111.9998 | $150,000 |
| Hartman Curt R | Jun 15, 2023 | Sell | 1,000 | $136 | $140,000 |
| Peters Stanley W III | Jun 8, 2023 | Sell | 5,000 | $131.1352 | $660,000 |
| Ferrell John D. | Jun 8, 2023 | Sell | 1,700 | $131.81 | $220,000 |
| CONCANNON BRIAN | Jun 7, 2023 | Sell | 812 | $129.01 | $100,000 |
| Peters Stanley W III | May 22, 2023 | Sell | 1,500 | $120.895 | $180,000 |
| Peters Stanley W III | May 18, 2023 | Sell | 1,500 | $119.2407 | $180,000 |
| CONCANNON BRIAN | May 1, 2023 | Sell | 2,072 | $125 | $260,000 |
| SHAGORY PETER K | Apr 28, 2023 | Sell | 2,442 | $128 | $310,000 |
| Pelletier Johonna Marie | Apr 28, 2023 | Sell | 5,400 | $126.18 | $680,000 |
| Pelletier Johonna Marie | Apr 28, 2023 | Sell | 5,100 | $126.37 | $640,000 |
| Pelletier Johonna Marie | Apr 28, 2023 | Sell | 4,800 | $126.33 | $610,000 |
| Pelletier Johonna Marie | Apr 28, 2023 | Sell | 2,000 | $126.45 | $250,000 |
| Pelletier Johonna Marie | Apr 28, 2023 | Sell | 1,317 | $127.06 | $170,000 |
| Jonas Daniel S | Apr 28, 2023 | Sell | 5,500 | $125.57 | $690,000 |
| Jonas Daniel S | Apr 28, 2023 | Sell | 4,300 | $126.72 | $540,000 |
| Berge Terence M | Apr 28, 2023 | Sell | 5,400 | $126.42 | $680,000 |
| Berge Terence M | Apr 28, 2023 | Sell | 5,100 | $126.65 | $650,000 |
| Berge Terence M | Apr 28, 2023 | Sell | 2,800 | $127.44 | $360,000 |
| Jonas Daniel S | Apr 28, 2023 | Sell | 200 | $127.56 | $26,000 |
| Hartman Curt R | Mar 14, 2023 | Sell | 5,000 | $92.8057 | $460,000 |
| Garner Todd W | Mar 13, 2023 | Sell | 17,926 | $91.1009 | $1.6M |
| Garner Todd W | Mar 13, 2023 | Sell | 6,849 | $90.3044 | $620,000 |
| Garner Todd W | Mar 13, 2023 | Sell | 3,825 | $91.9452 | $350,000 |
| Garner Todd W | Mar 13, 2023 | Sell | 1,300 | $88.7819 | $120,000 |
| Garner Todd W | Mar 13, 2023 | Sell | 100 | $92.63 | $9,300 |
| Jonas Daniel S | Mar 2, 2023 | Sell | 5,400 | $96.245 | $520,000 |
| Jonas Daniel S | Mar 2, 2023 | Sell | 5,000 | $96.0762 | $480,000 |
| Garner Todd W | Dec 9, 2022 | Sell | 4,500 | $89.31 | $400,000 |
What's the latest insider transaction for Conmed?
The most recent insider transaction for Conmed was conducted by Peters Stanley W III, who sold 4,000 shares on June 14, 2024 at a price of $71.82 per share.
Which insider bought the most CNMD stock over the last two years?
Beyer Pat has bought the most CNMD stock in the last 2 years, with a total value of $200,000.
Which insider has sold the most CNMD stock over the last two years?
Garner Todd W has sold the most CNMD stock in the last 2 years, with a total value of $3.3M.
What is the total value of insider transactions for Conmed (CNMD) in the last 2 years?
The total value of insider transactions for Conmed in the last 2 years is negative, amounting to -$12M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Conmed's market confidence?
Over the last 2 years, insider transactions for Conmed have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
